IG rearrangement, JAK1/2 inhibition and aggressive B-cell lymphoma development...
10 Jul 2018
IG rearrangement, JAK1/2 inhibition and aggressive B-cell lymphoma development...
The TAPUR trial family: a global data sharing platform
Biobanking and early diagnosis to defeat NSCLC
WINTHER & SPRING: Targeted agents and triple agent combinations
Lessons from long-term survey of stage I NSCLC
Precision CAR T cell therapeutics
Implementing precision medicine in oncology: The IMPACT trials
MyPathway study: a novel precision oncology multiple basket trial
Editor's Choice for June 2018
CDK6 a transcriptional regulator in AML
ASCO 2018 conference round up
First in-human trial of AMV564 for AML